Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Net Income (2016 - 2025)

Tandem Diabetes Care's Net Income history spans 13 years, with the latest figure at -$510000.0 for Q4 2025.

  • For Q4 2025, Net Income fell 165.81% year-over-year to -$510000.0; the TTM value through Dec 2025 reached -$204.6 million, down 113.23%, while the annual FY2025 figure was -$204.7 million, 113.18% down from the prior year.
  • Net Income reached -$510000.0 in Q4 2025 per TNDM's latest filing, up from -$21.2 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $10.8 million in Q4 2021 to a low of -$130.6 million in Q1 2025.
  • Average Net Income over 5 years is -$30.1 million, with a median of -$22.2 million recorded in 2024.
  • Peak YoY movement for Net Income: skyrocketed 161.38% in 2021, then plummeted 944.34% in 2022.
  • A 5-year view of Net Income shows it stood at $10.8 million in 2021, then crashed by 247.66% to -$15.9 million in 2022, then tumbled by 88.54% to -$30.0 million in 2023, then soared by 102.59% to $775000.0 in 2024, then tumbled by 165.81% to -$510000.0 in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Net Income are -$510000.0 (Q4 2025), -$21.2 million (Q3 2025), and -$52.4 million (Q2 2025).